StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioNTech (BNTX) PT Lowered to $93 at Morgan Stanley
August 5, 2024 2:32 PM
Morgan Stanley analyst Terence Flynn lowered the price target on BioNTech (NASDAQ: BNTX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Midday movers: Apple, Nvidia, Intel, Coinbase and Moderna fall
August 5, 2024 7:35 AM
BioNTech counts on shift to cancer drugs after second quarter losses quadruple
August 5, 2024 6:57 AM
Form 6-K BioNTech SE For: Jun 30
August 5, 2024 6:35 AM
Form 6-K BioNTech SE For: Aug 05
August 5, 2024 6:33 AM
BioNTech SE (BNTX) Misses Q2 EPS by 134c, reiterates guidance
August 5, 2024 6:05 AM
BioNTech SE (BNTX) call put ratio 2.4 calls to 1 put with focus on September 82.50 calls
August 2, 2024 2:58 PM
HSBC Upgrades BioNTech (BNTX) to Buy
August 2, 2024 4:02 AM